Skip to content
Tech News
← Back to articles

DARPA funds $73 million push for synthetic blood substitute

read original get North American Rescue Combat Gauze → more articles
GoKawiil Brief

DARPA, the Pentagon's research arm, has launched a $73 million program led by Navy Lt. Cmdr. Robert Murray to develop a synthetic blood alternative for battlefield use. The effort responds to chronic blood shortages that researchers say cause roughly 10,000 preventable deaths annually in the US and far more worldwide, largely due to blood's short shelf life once thawed or stored.

Why It Matters

GoKawiil's interpretation of the reporting above, not reported fact.

Hemorrhage causes about 90% of preventable combat deaths, and a 2025 Transfusion study found only 1% of US trauma patients who likely needed blood actually received it before hospital arrival, suggesting the logistics gap is severe. A viable synthetic blood product could extend the window for treating trauma in remote or combat settings, potentially benefiting civilian emergency care as well, though such technology remains unproven and years from deployment.

Key Takeaways
Worth a Look

North American Rescue Combat Gauze — While synthetic blood is still in development, hemostatic gauze is a proven, field-tested tool for controlling severe bleeding right now, the same kind of hemorrhage this article identifies as the top cause of preventable battlefield deaths. It's a practical, real-world complement to any first aid or trauma kit for outdoor enthusiasts, preppers, or anyone interested in emergency medicine.

See North American Rescue Combat Gauze on Amazon → Affiliate link — we may earn a commission on purchases, at no extra cost to you. Product picked by AI based on this article; it is not a tested recommendation.

Source: technologyreview.com — Andrew Rosenblum, 2026-10-14

Published there as: “The US military’s race to make fake blood”

Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.